Kristine Pelton

Kristine Pelton

UNVERIFIED PROFILE

Are you Kristine Pelton?   Register this Author

Register author
Kristine Pelton

Kristine Pelton

Publications by authors named "Kristine Pelton"

Are you Kristine Pelton?   Register this Author

20Publications

574Reads

7Profile Views

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.

Cell 2019 Aug 18;178(4):835-849.e21. Epub 2019 Jul 18.

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2019.06.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6703186PMC
August 2019

Serum cholesterol levels and tumor growth in a PTEN-null transgenic mouse model of prostate cancer.

Prostate Cancer Prostatic Dis 2018 06 23;21(2):196-203. Epub 2018 May 23.

Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41391-018-0045-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026483PMC
June 2018

Leveraging molecular datasets for biomarker-based clinical trial design in glioblastoma.

Neuro Oncol 2017 Jul;19(7):908-917

Department of Radiation Oncology, Department of Pathology, Center for Neuro-Oncology, Dana-Farber/Brigham & Women's Cancer Center (DF/BWCC), Harvard Medical School, Boston, Massachusetts; Department of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; Accelerate Brain Cancer Cure (ABC2), Washington, DC; Harvard Program in Therapeutic Science, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now312DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570228PMC
July 2017

Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas.

Clin Cancer Res 2016 Mar 19;22(5):1185-96. Epub 2015 Oct 19.

Inserm, U 1127, Paris, France. CNRS, UMR 7225, Paris, France. Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France. Institut du Cerveau et de la Moëlle épinière, ICM, 47, Bd de l'Hôpital, Paris, France. AP-HP, Hôpital universitaire Pitié-Salpêtrière, Service de Neurologie 2-Mazarin, 47, Bd de l'Hôpital, Paris, France. AP-HP, Hôpital de la Pitié-Salpêtrière, Service de Neuropathologie R Escourolle, 47, Bd de l'Hôpital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842012PMC
March 2016

Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo.

Am J Pathol 2014 Jul;184(7):2099-110

The Program in Vascular Biology, Boston Children's Hospital, Boston, Massachusetts; Department of Surgery, Harvard Medical School, Boston Children's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2014.03.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076468PMC
July 2014

Cholesterol and prostate cancer.

Curr Opin Pharmacol 2012 Dec 21;12(6):751-9. Epub 2012 Jul 21.

The Urological Diseases Research Center, Boston Children's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coph.2012.07.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515742PMC
December 2012

The response of the prostate to circulating cholesterol: activating transcription factor 3 (ATF3) as a prominent node in a cholesterol-sensing network.

PLoS One 2012 2;7(7):e39448. Epub 2012 Jul 2.

Division of Cancer Biology and Therapeutics, Departments of Surgery and Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0039448PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388073PMC
November 2012

Hypercholesterolemia promotes an osteoporotic phenotype.

Am J Pathol 2012 Sep 4;181(3):928-36. Epub 2012 Jul 4.

Department of Orthopaedic Surgery, Children's Hospital Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2012.05.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432436PMC
September 2012

Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors.

PLoS One 2012 18;7(1):e30062. Epub 2012 Jan 18.

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0030062PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261168PMC
July 2012

FosB regulates stretch-induced expression of extracellular matrix proteins in smooth muscle.

Am J Pathol 2011 Dec 11;179(6):2977-89. Epub 2011 Oct 11.

Urological Diseases Research Center, Children's Hospital Boston, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2011.08.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260854PMC
December 2011

Prohibitin is a cholesterol-sensitive regulator of cell cycle transit.

J Cell Biochem 2010 Dec;111(5):1367-74

Department of Orthopaedic Surgery, Children's Hospital Boston, 300 Longwood Avenue, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jcb.22865
Publisher Site
http://dx.doi.org/10.1002/jcb.22865DOI Listing
December 2010

Ezetimibe reduces enlarged prostate in an animal model of benign prostatic hyperplasia.

J Urol 2010 Oct 21;184(4):1555-9. Epub 2010 Aug 21.

Department of Orthopaedic Surgery, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2010.05.083DOI Listing
October 2010

Ezetimibe is an inhibitor of tumor angiogenesis.

Am J Pathol 2009 Mar 29;174(3):1017-26. Epub 2009 Jan 29.

Dept. of Orthopaedic Surgery, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2353/ajpath.2009.080551DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2665761PMC
March 2009